Bioarray Therapeutics
Boston
About Bioarray Therapeutics
BIOARRAY's Therapeutics, Inc. (BIOARRAY) is a privately held start up biotechnology company founded in 2009 in Boston, MA. BIOARRAY is developing proprietary predictive diagnostic tests, based on cancer genes (markers), to choose to the most efficacious treatment for cancer patients beforehand, rather than the trial and error approach currently used.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2017)
- Website: bioarray.us
- Phone: 8606797128
Industries & Categories
Biopharma, Biotechnology, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/bioarray-therapeutics-47024 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.